* Healthequity Inc HQY.OQ HQY.O is expected to show a
rise in
quarterly revenue when it reports results on June 5.
* The Draper Utah-based company is expected to report a
16.4% increase in revenue to $239.427 million from $205.68
million a year ago, according to the mean estimate from 13
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Healthequity Inc is
for
earnings of 41 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.
* Wall Street's median 12-month price target for
Healthequity Inc
is $82, above its last closing price of $55.63.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jan. 31 2023 0.35 0.35 0.37 Beat 6
Oct. 31 2023 0.35 0.35 0.38 Beat 9.7
Jul. 31 2022 0.33 0.33 0.33 Met 0
Apr. 30 2022 0.25 0.26 0.27 Beat 3.8
Jan. 0.21 0.22 0.20 Missed -7.8
31 2022
Oct. 31 2021 0.35 0.35 0.35 Met 0.8
Jul. 31 2021 0.36 0.36 0.40 Beat 10.9
Apr. 30 2021 0.31 0.32 0.38 Beat 18.1
This summary was machine generated June 2 at 20:23 GMT. All
figures in US dollars unless otherwise stated